Drug Shortage Report for TEVA-RIVAROXABAN

Last updated on 2024-02-15 History
Report ID 219671
Drug Identification Number 02507218
Brand name TEVA-RIVAROXABAN
Common or Proper name RIVAROXABAN 15MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RIVAROXABAN
Strength(s) 15MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3x10
ATC code B01AF
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-14
Estimated end date 2024-05-31
Actual end date
Shortage status Actual shortage
Updated date 2024-02-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-02-15 English Compare
v2 2024-02-15 French Compare

Showing 1 to 2 of 2